The placenta is essential for the efficient delivery of nutrients and oxygen from mother to
fetus to maintain normal fetal growth. Dysfunctional placental development underpins many …

Effective screening for the development of early onset preeclampsia (PE) can be provided in
the first‐trimester of pregnancy. Screening by a combination of maternal risk factors, uterine …

Objectives To determine the accuracy with which uterine artery Doppler in the first trimester
of pregnancy predicts pre‐eclampsia and fetal growth restriction, particularly early‐onset …

Fetal intrauterine growth restriction presents a complex management problem for the
clinician. The failure of a fetus to achieve its growth potential imparts a significantly …

Health care provision is increasingly focused on the prediction of patients' individual risk for
develo** a particular health outcome in planning further tests and treatments. There has …

Reduced fetal growth is seen in about 10% of the pregnancies but only a minority has a
pathological background and is known as intrauterine growth restriction or fetal growth …

Fetal growth restriction (FGR) remains a leading contributor to perinatal mortality and
morbidity and metabolic syndrome in later life. Recent advances in ultrasound and Doppler …

Objective: To review the obstetrical outcomes associated with abnormally elevated or
decreased level of one or more of the most frequently measured maternal serum marker …

Objective. Changes in the maternal plasma concentrations of angiogenic (placental growth
factor (PlGF) and vascular endothelial growth factor (VEGF)) and anti-angiogenic factors …

Objectives To examine the relationship between low maternal serum pregnancy‐associated
plasma protein‐A (PAPP‐A) and uterine artery pulsatility index (UtA‐PI) at 11+ 0 to 13+ 6 …